Yazar "Çolak, Mustafa" için listeleme
-
Allergic rhinitis in the etiology of obstructive sleep apnea
Çolak, Mustafa; Sarıoğlu, Nurhan; Köse, Mehmet; Çoban, Hikmet; Erel, Fuat (Bayrakol Medical Publisher, 2022)Aim: In this study, it was aimed to determine the prevalence of allergic rhinitis in patients with obstructive sleep apnea syndrome and to investigate the effect of allergic rhinitis on the severity of obstructive sleep ... -
Can the HALP score predict survival in severe COVID-19 pneumonia?
Çolak, Mustafa; Uçkun, Serkan; Çoban, Hikmet; Sarıoğlu, Nurhan; Erel, Fuat (Polish Acad Sciences, 2023)Introduction The coronavirus infection has caused a pneumonia pandemic worldwide. Our study aimed to determine the relationship between the HALP score and survival in patients monitored in the intensive care unit due to ... -
Clinical characteristics and outcomes of nosocomial COVID-19 in Turkey: A retrospective multicenter study
Yıldırım, Süleyman; Yılmaz, Celalettin; Polat, Gülru; Barış, Serap; Başyiğit, İlknur; Kaya, İlknur; Anar, Ceyda; Çolak, Mustafa (Wolters Kluwer Medknow Publications, 2023)Objective: To identify the clinical characteristics and outcomes of hospital-acquired SARS-CoV-2 infection during the vaccination period nationwide in Turkey. Methods: COVID-19 patients followed in the pandemic services ... -
Could hepcidin be a new biomarker in patients with idiopathic pulmonary fibrosis (IPF)?
Yılmaz, Gülçin; Çoban, Hikmet; Sarıoğlu, Nurhan; Erel, Fuat; Yılmaz, Merve Akış; Çolak, Mustafa; Şenel, Merve Yumrukuz; Hişmioğulları, Adnan Adil (MDPI, 2024)Hepcidin is a biomarker produced by hepatocytes in chronic disease anemia and is known to increase during chronic inflammation. This study compares the hepcidin levels in idiopathic pulmonary fibrosis (IPF) patients and ... -
Could the HALP score serve as a biomarker of bronchiectasis exacerbation?
Çolak, Mustafa; Çoban, Hikmet; Sarıoğlu, Nurhan; Şenel, Merve Yumrukuz; Erel, Fuat (Tuba Yıldırım, 2024)Introduction: Bronchiectasis is a chronic inflammatory lung disease and patients may occasionally experience acute exacerbations. Our study aims to determine the relationship between exacerbation periods and HALP ... -
Efficacy of mepolizumab and omalizumab combination therapy in uncontrolled asthma
Sezgin, Mehmet Emin; Çolak, Mustafa; Çağlayan, Özge; Şenel, Merve Yumruksuz; Sezgin, Esma Nur Aktepe; Çoban, Hikmet; Sarıoğlu, Nurhan; Gemicioğlu, Bilun; Erel, Fuat (Taylor and Francis Ltd., 2023)Objective: Results of biological therapies are often encouraging for severe asthma who are phenotyped as Type 2 inflammation. Unfortunately, some patients do not achieve the desired responses. In this group of patients, ...
